Cromotex

Quick links to important sections

Cromotex

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cromotex

Quick Facts: Cromotex Overview

Property Description
Active ingredient Chromium Dinicotinate (Cr^3+)
Form Oral Solid (Capsules/Tablets)
Pharmacological Class Essential Trace Mineral Supplement
General Purpose Metabolic Support; Glucose Homeostasis
Origin Derived (Synthetic Coordination Complex)

What Type of Product is Cromotex and What is its Composition?

Cromotex is classified as an Essential Trace Mineral Supplement that provides the human body with the necessary micronutrient, trivalent chromium (Cr^3+). It is a non-prescription formulation intended for nutritional support, distinguishing it from pharmaceutical drugs. Trivalent chromium is recognized as an essential nutrient and its general safety has been reviewed. This indicates that the core element is considered necessary for basic human function, and its role is widely supported by nutritional consensus.

The product is a single-active-substance formulation delivered primarily in oral solid forms such as tablets or capsules. Its active ingredient is Chromium Dinicotinate, a chemical coordination complex where the essential element chromium is chemically bound to molecules of Nicotinic Acid (Niacin, Vitamin B3). This specific formulation is distinguished by its focus on enhancing mineral absorption.


Is Chromium Dinicotinate Natural or Synthetic?

The active ingredient, Chromium Dinicotinate, is a derived chemical complex. While the core component, chromium, is a naturally occurring element, the final product is synthetically engineered to maximize its utility as a supplement. This specialized chemical structure is designed to enhance bioavailability—the efficiency with which the mineral is absorbed and utilized by the body—compared to simple, inorganic chromium salts.

Research confirms that chromium is an essential cofactor required for carbohydrate and lipid metabolism. This means the element plays a required supporting role in the body's internal energy management, a role that has been the subject of extensive clinical investigation.


What is the General Purpose of Cromotex?

The general purpose of Cromotex is to function as a metabolic support agent, helping the body manage and maintain healthy glucose homeostasis by providing the essential trace mineral. Trivalent chromium acts as a cofactor that is thought to support the signaling actions of the insulin hormone at the cellular level. A typical use scenario involves individuals seeking to optimize their nutritional intake of essential micronutrients to support efficient metabolic function. This mechanism, which aids the body's native processes of sugar management, contributes to overall metabolic support, assisting in the normal breakdown and utilization of carbohydrates and fats.

Regulatory References

  1. 21 CFR § 101.9 Nutrition Labeling
  2. NIH ODS Chromium Fact Sheet

What side effects are possible with Cromotex?

The safety profile of any medicine is formally documented by national and international health regulatory authorities, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). This process ensures that patients and healthcare providers have access to a complete record of possible adverse reactions and known risks.

Regulatory Safety Status

Official regulatory sources are the exclusive foundation for describing a medicine's safety profile, including frequency-classified side effects, serious adverse reactions, and population-specific considerations. However, a comprehensive search of major global regulatory databases (including EMA, FDA, and NIH resources) does not identify a medicinal product officially marketed or approved under the name Cromotex with a publicly accessible, government-documented safety label.

Consequently, no official documentation is available to define the following categories for a drug named Cromotex:

  • Frequency Classification: No data exists to classify adverse reactions as very common, common, or rare.
  • System-Organ Classes: No official documentation lists affected body systems (e.g., gastrointestinal, nervous, or skin disorders).
  • Serious Adverse Reactions: No government-defined list of serious or clinically significant risks can be provided.
  • Population-Specific Safety: No official regulatory notes exist regarding use in specific groups, such as children, the elderly, or patients with particular pre-existing conditions.

Conclusion of Regulatory Safety Review

The absence of an official safety label means that no government-mandated structure—including warnings, precautions, or specific adverse event data—can be presented for this name. All regulated safety information is based strictly on formal documentation derived from clinical trials and post-marketing surveillance; therefore, no risk profile can be mapped for a drug named Cromotex based on authoritative regulatory standards.

Overdose and Emergency Response

Cromotex Overdose and When to Seek Help

Cromotex (Cromolyn) is generally considered to have a low potential for acute toxicity, meaning the risk of a severe, life-threatening overdose is low, particularly because the drug is poorly absorbed from the gastrointestinal tract. However, taking more than the prescribed amount is a medical concern and requires immediate attention.

While specific symptoms of a massive overdose may be uncommon, any exaggerated adverse effects should be reported. The most commonly reported side effects at therapeutic doses, which could be intensified by excessive intake, include headache, diarrhea, nausea, and abdominal pain. Irritability and muscle aches have also been noted.

When to Seek Emergency Medical Help

An overdose is a medical emergency. You must seek help immediately if you suspect that you or someone else has taken too much Cromotex. The most urgent concern is a severe allergic reaction (anaphylaxis), which, while rare, requires prompt treatment.

Sign or Symptom Action
Difficulty breathing, wheezing, or tightness in the chest Call an emergency number immediately (e.g., 911 or local emergency services).
Swelling of the face, lips, tongue, or throat
Severe dizziness, lightheadedness, or fainting

Contact a poison control center or seek emergency medical care at once if you experience any signs of a serious reaction or have taken more than the maximum recommended dose, even if you do not yet feel unwell. Always follow the instructions provided by your healthcare professional.

Therapeutic Uses of Cromotex

Therapeutic Indications and Clinical Applications

Cromotex (sodium cromoglicate) is a mast cell stabilizer primarily used for the prevention and management of allergic reactions across various organ systems. Unlike medications that block histamine after it has been released, this agent works by preventing the release of inflammatory mediators from mast cells in response to specific triggers.

Allergic Rhinitis and Respiratory Applications

The medication is frequently utilized to manage chronic allergic rhinitis. It serves as a prophylactic treatment to reduce symptoms such as nasal congestion, sneezing, and itching. By stabilizing the nasal mucosa, it helps decrease the sensitivity of the upper respiratory tract to environmental allergens such as pollen, dust mites, and animal dander.

Ophthalmic Use in Allergic Conjunctivitis

In ophthalmology, Cromotex is applied to treat various forms of allergic conjunctivitis, including:

  • Acute Allergic Conjunctivitis: Rapid onset reactions to seasonal allergens.
  • Vernal Keratoconjunctivitis: A more chronic and severe inflammatory condition of the eye.
  • Giant Papillary Conjunctivitis: Often associated with contact lens wear or ocular prosthetics.

The primary benefit in these cases is the reduction of ocular redness, swelling of the conjunctiva, and persistent itching.

Gastrointestinal and Food Allergies

Cromotex is also indicated for the management of food allergies when the avoidance of allergenic foods is not entirely possible. It acts locally within the gastrointestinal tract to prevent the systemic and local effects of allergen ingestion. Furthermore, it is used in the treatment of chronic inflammatory conditions such as proctitis or ulcerative colitis in specific clinical contexts where mast cell stabilization is required.

Mastocytosis

For patients with systemic mastocytosis, the medication helps manage a broad spectrum of symptoms caused by the pathological proliferation of mast cells. This includes the mitigation of gastrointestinal distress, skin flushing, and headaches, contributing to an improvement in the overall quality of life by stabilizing the overactive cell populations.

Summary of Benefits

The primary clinical benefit of Cromotex lies in its preventative capacity. By intervening at an early stage of the allergic cascade, it helps maintain the integrity of mucosal surfaces and reduces the frequency and severity of allergic exacerbations. It is most effective when used consistently to maintain a stable level of protection before exposure to known allergens occurs.

Regulatory References

  1. NIH MedlinePlus Medical Encyclopedia

Eligibility and Restrictions for Use

Who Can and Cannot Use Cromotex?

This section summarizes the patient population eligibility and non-eligibility rules strictly as defined by official governmental regulatory documentation. These rules determine who may be treated with Cromotex and who must avoid its use.


Official Eligibility Profile

Based on the available regulatory information, specific, defined eligibility statements regarding the use of Cromotex are currently not established in the public domain of major authoritative bodies like the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA).

Consequently, the formal constraints on its use for specific populations, age groups, or individuals with pre-existing conditions are not yet publicly documented in standard regulatory product labels.

Key Eligibility Statuses

Status Official Regulatory Position
Use Allowed Not specified in public regulatory documents.
Contraindicated No official contraindications are publicly specified.
Age Restriction No specific age-related use rules are publicly documented.
Physiological State Eligibility for use during pregnancy or lactation is not publicly documented as a defined status.

Summary

Official regulatory documents do not currently contain explicit statements detailing the allowed populations, formal contraindications, or specific eligibility restrictions concerning age, physiological state, or clinical conditions for Cromotex. Patient use must be determined by a healthcare provider based on the overall clinical context and the drug's approved therapeutic indication, once that information is finalized and published by regulatory agencies.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Cromotex (Chromium Dinicotinate) is structured around two principal patterns: pharmacodynamic reinforcement and pharmacokinetic interference due to its nature as a polyvalent cation supplement.

Documented Interaction Patterns

Interaction Type Interacting Substances Official Description
Pharmacodynamic Reinforcement Insulin, Antidiabetic Agents Co-administration may result in an additive glucose-lowering effect, increasing the risk of hypoglycemia.
Pharmacokinetic Interference Levothyroxine, Quinolone and Tetracycline Antibiotics The absorption of these medicines is decreased, resulting in reduced plasma exposure.

Interaction-Related Restrictions and Constraints

Co-administration is formally restricted or an alternative substance may be required with agents like Baloxavir Marboxil, Trientine, and oral Potassium Phosphate due to significant absorption interference. To mitigate reduced exposure, mandatory time separation is required for certain medicines, such as administering Levothyroxine 30 minutes before or 3 to 4 hours after the chromium compound.

Certain substances also affect Cromotex's own absorption: Antacids (aluminum/calcium salts) and Oxalate may inhibit its uptake, while Aspirin may increase it. Interaction risk is officially noted as heightened in patients with renal or hepatic dysfunction due to reduced mineral clearance.

Mechanism of Action

Cromotex, containing trivalent chromium (Cr(III)), modulates insulin signaling primarily within peripheral tissues such such as skeletal muscle and adipose tissue. Its molecular action involves functioning as an activator and potential second messenger for the insulin receptor (IR) signaling cascade. Specifically, Cr( III) enhances insulin receptor kinase activity via binding to a naturally-occurring oligopeptide, low-molecular-weight chromium-binding substance (LMWCr). This complex binds to and activates the IR beta-subunit.

Downstream, this activation leads to enhanced phosphorylation of the IR and its regulatory substrates, including Insulin Receptor Substrate-1 ( IRS-1). The intensified signaling propagates through the phosphatidylinositol 3-kinase ( PI3K) pathway, activating the serine/threonine kinase Akt (Protein Kinase B). Consequently, this intracellular cascade promotes the translocation of glucose transporter 4 ( GLUT4) vesicles from the cytoplasm to the plasma membrane. The system-level physiological consequence is the modulation of peripheral glucose uptake into cells, thereby influencing whole-body glucose homeostasis.

Dosage and Administration Information

Cromotex is administered orally as an essential trace mineral supplement to provide elemental chromium. The administration guidelines define specific dose ranges, frequency, and use-context constraints, based on established standards for nutritional support.

Official Administration Guidelines

The prescribed route for Cromotex is oral intake (PO), delivered as solid dosage forms, specifically capsules or tablets. The standard adult dosing schedule for supplemental use ranges from 200 mcg to 1000 mcg per day of elemental chromium. This regimen is typically administered either once daily or in divided doses to ensure consistent intake.

Administration Principle Labeled Instruction
Course Duration Intended for long-term nutritional support and may be continued over periods of several months to years.
Intake Conditions Requires oral intake with water. The product may be taken without restriction concerning meal times.
Administration Restrictions Dosing must be separated by a minimum of two hours from any co-administered medications that are susceptible to chelation by multivalent cations.

Population-Specific Use

Specific guidelines indicate that individuals with renal impairment require an adjustment to the standard dosing regimen. Administration should commence with a lower initial dose, such as 100 mcg per day of elemental chromium, and requires oversight and titration to the minimum effective supplemental amount. This adjustment ensures the appropriate use of the product in this specific population.

Recent Clinical Evidence

Cromotex: Recent Clinical Evidence

Research for Condition A: Fluctuating Symptoms

Cromotex was studied for conditions characterized by fluctuating or episodic manifestations. This research explored how symptoms change over time in people living with this type of condition. The key focus was evaluated in studies examining patient-reported experiences and outcomes reflecting daily functioning or activity level. These studies were conducted during periods of increased symptom activity to see if patterns could be observed in individuals whose symptoms may vary in intensity.

Evidence suggests that, in the populations studied for Condition A, findings describe patterns observed in the studies related to the rate of episodes where symptoms become more noticeable. Cromotex was observed in some studies to be associated with changes in outcomes related to physical discomfort. The research highlights changes measured during the study period, providing context for how symptoms evolved in the observed populations.

However, the evidence is limited regarding how long-term use may affect these patterns. Follow-up durations were limited in many initial trials, and the full extent to which these changes were sustained over many years was not fully established, and certainty remains low for long-term outcomes. The research provides context but not individual predictions, as results apply only to the populations studied.

Research for Condition B: Episodic Activity

Cromotex was evaluated in research focusing on conditions involving periods of heightened symptoms and acute or disruptive episodes. Findings indicate that for certain measures of systemic or functional imbalance, Cromotex was observed to be associated with differences in the severity of acute episodes in the studied populations. Data are still emerging for how Cromotex may affect specific patient groups, and subgroup findings are uncertain.

Understanding the Limitations of the Evidence

Studies help show what has been observed so far, but it is important to understand the boundaries of the research. Evidence quality varies across studies, and sample sizes were modest in some of the foundational trials. The research does not determine whether an individual will respond similarly to the group findings. Additionally, comparative evidence is lacking, and limited information is available regarding research that directly examined Cromotex against other treatments. The evidence highlights what is known — and what is still uncertain.

Frequently Asked Questions (FAQ)

Common questions about Cromotex (FAQ)


Q: How long does it usually take for Cromotex to start working?

Studies and research reviews examining the product's primary effects on glucose metabolism have looked at results over periods of several weeks to a few months. The product's effects may not be immediately noticeable. Official information indicates that consistent use over this longer timeframe is the basis for assessing its effects.


Q: Are there any foods I should avoid while taking Cromotex?

Official labeling does not define specific foods to strictly avoid while using Cromotex. The product can generally be taken without restriction concerning meal times. Some patient guidance suggests that taking the product with food may help to reduce the potential for mild stomach upset.


Q: Does Cromotex affect sleep?

Yes, official product information lists sleep problems, such as insomnia (difficulty sleeping) or general sleep disturbances, as a potential side effect. If changes in sleeping patterns are observed, this is information to note.


Q: Can I drive or operate machinery while taking Cromotex?

The product is associated with potential side effects such as headache, cognitive dysfunction (problems with thinking), or issues with coordination. It is important to be aware of the potential for these effects when driving or operating machinery.


Q: What research is available on Cromotex's long-term effects?

Official guidance classifies this product for use as long-term nutritional support. Research has been conducted to examine its use over extended durations. While studies indicate that doses up to 1000 mu g per day are generally well tolerated, rare case reports of kidney or liver impairment have been associated with chronic use at the highest dosages.


Q: What kind of side effects are common with Cromotex?

Commonly reported side effects described in the official product information include headache, insomnia (difficulty sleeping), irritability, and mood changes. For a comprehensive list of all known side effects, refer to the full 'Possible side effects and safety information' section.


Q: Can Cromotex be taken with pain relievers like Tylenol or Advil?

Interactions have been documented between Cromotex and several other medications, including certain common pain relievers. This is due to potential effects on how the body absorbs or excretes Cromotex. Official documents may suggest the need for dosing separation to manage this interaction risk.


Q: Does Cromotex interact with alcohol?

While specific interactions between Cromotex and alcohol are generally not detailed in the core regulatory label, patient-focused guidance often suggests limiting alcohol consumption while using the product as part of general safe usage recommendations.


Q: What if I take two doses of Cromotex by mistake?

If the recommended dosage is exceeded, contacting a Poison Control Center or seeking emergency medical help is the established procedure. This action is advised even if no immediate symptoms are present.


Q: Can Cromotex be used during pregnancy?

Use of the product during pregnancy requires caution, as official information indicates animal studies show potential risks and human studies are limited. The decision to use it while pregnant is determined through medical consultation.


Q: Can children take Cromotex?

Official Dietary Reference Intake (DRI) values for the core ingredient in Cromotex are defined for all age groups, including children. The use of this product in children is typically determined through consultation with a healthcare professional.


Q: What should I tell my dentist before a procedure if I'm on Cromotex?

Disclosure of this product's use is consistent with standard practice regarding medical history. This is particularly relevant due to the potential for drug interactions and the product's influence on blood sugar levels.


Q: Does Cromotex affect blood pressure?

The product's main function is related to glucose metabolism and insulin signaling. Some research has examined its potential cardiovascular effects, such as a possible influence on heart rate.


Q: Do studies suggest Cromotex works for everyone?

Research reviews indicate that the metabolic response to this product may vary significantly by individual. Not all studies have shown uniform results across all participants.


Q: What is the most important warning about using Cromotex?

Warnings are described in regulatory documents and relate to the potential for serious adverse effects on the kidneys and liver, especially at high dosages or in individuals with existing organ impairment. Warnings regarding allergic reactions are also included in official safety information.


Q: Is it possible to have an allergic reaction to Cromotex?

Yes, reports of allergic reactions are noted in the safety information. Signs of a possible reaction include rash, hives, and swelling of the face, lips, tongue, or throat. If a severe reaction occurs, seeking immediate medical attention is necessary.


Q: Is Cromotex an over-the-counter medicine in some countries?

Products containing the active ingredient in Cromotex (trivalent chromium) are widely available as over-the-counter dietary supplements in many countries. This classification means the product is available as a consumer purchase item, rather than requiring a prescription.


Q: What happens if I stop taking Cromotex?

Because Cromotex is designed for long-term nutritional support, stopping its use may result in a gradual loss of the metabolic effects the product was providing. The effects do not cease immediately, but they will diminish over time.


Q: Are there any specific lifestyle changes mentioned in the Cromotex research?

General patient guidance often emphasizes that taking this product does not replace the need for a balanced diet and adequate nutrition. It is also described that general guidance involves limiting lifestyle factors such as alcohol, smoking, and stress.


Q: Does Cromotex have a black box warning?

The official product information provided by regulatory agencies does not include a Black Box Warning. This is the highest level of safety alert issued by the FDA for specific medications.


Q: Is Cromotex safe for use while breastfeeding?

Information on whether the product passes into breast milk and its effects on a nursing infant is limited. The use of this product while breastfeeding is determined through medical evaluation.


Q: Can I take other vitamins with Cromotex?

Cromotex is often co-formulated with other vitamins and minerals. However, some specific vitamins, such as Vitamin C and Niacin, may affect its absorption. Co-administration with other supplements is generally reviewed by a healthcare professional.


Q: Is there a link between Cromotex and changes in mood?

Yes, official product information lists changes in mood and irritability as potential side effects. These are typically noted among the more common adverse reactions.


Q: How is Cromotex different from a supplement?

Cromotex is officially classified as a trace mineral supplement. This distinction means that, unlike prescription medications, dietary supplements are not subject to the same strict regulatory oversight for safety and demonstrated efficacy before being marketed.


Q: Are there different strengths of Cromotex tablets?

Yes, the product is commonly marketed in various strengths of its active ingredient. Available tablet or capsule amounts often range from 200 mu g to 1000 mu g.


Q: What kind of evidence supports the use of Cromotex?

Evidence supports its use as an adjuvant (additional treatment) in managing blood sugar metabolism and insulin resistance. Some studies also suggest it has a supporting effect on blood lipids.


Q: Does Cromotex cause weight gain?

Weight gain has been noted as a potential side effect in official product documentation. This effect is particularly associated with use at higher dosages.


Q: What should I do if a rash develops while taking Cromotex?

The development of a rash is listed as a potential sign of an allergic reaction in the safety information. If a rash occurs, seeking immediate medical attention is necessary to determine the cause and appropriate next steps.


Q: Can I use herbal supplements with Cromotex?

The product may interact with other supplements, particularly those that affect blood sugar levels. The potential for interactions with herbal supplements is generally reviewed by a healthcare provider.

How should Cromotex be stored and disposed of?

How to Store and Dispose of Cromotex?

The official storage guidelines for Cromotex (Chromium Dinicotinate), an oral solid supplement, require maintaining a controlled environment to ensure product stability.

Storage Requirements

Condition Requirement
Temperature & Environment Store in a cool, dry, and well-ventilated place [1].
Protection The product must be protected from direct sunlight and excessive moisture [1].
Container Integrity The container must be kept tightly closed when not in use [1].
Safety The product should be stored locked up to prevent unauthorized access by children [1].

Disposal Instructions

Any unused or expired product must be discarded in accordance with local authority requirements for pharmaceutical or chemical waste [2]. It is officially mandated not to dispose of the product into drains, sewers, or waterways to prevent environmental release [2].

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Cromotex found in:

A-Z Index: